Related Experiment Videos
Polyamine deprivation: a new tool in cancer treatment
V Quemener1, Y Blanchard, L Chamaillard
1Laboratoire de Biologie Cellulaire, Centre Hospitalier-Universitaire de Rennes, France.
Abstract:
The fact that tumors require polyamines for growth has been demonstrated in vitro and in vivo and widely reported. This finding led to the use of polyamine biosynthetic enzymes as targets for antitumor drug design. Highly efficient in vitro selective inhibitors of ornithine decarboxylase such as DFMO do not produce important antitumoral effects in vivo, due to the ability of tumor cells to uptake extracellular polyamines. A new strategy was developed, combining a systematic blockade of all endogenous and exogenous sources of polyamines in vivo. Sources of exogenous polyamines were eliminated by administration of a polyamine-free diet to the animals and decontamination of their gastrointestinal tract. Important antitumoral effects were obtained with this polyamine deprivation and are presented with two experimental models of tumors (Lewis lung carcinoma, Mat Lylu prostatic carcinoma). Biological parameters, modified in cases of cancer, were restored to normal values in treated animals: blood counts and NK cytotoxic activity. Number of metastases was significantly reduced. Given that in man cancer treatment remains unsatisfactory due to incomplete cell kill, development of resistance to treatment and secondary effects of chemotherapy, we chose to investigate the potential interest of polyamine deprivation in this field. By combining clinically applied cytotoxic drugs with polyamine deprivation, we observed an improvement of their antitumoral efficiency: a considerable retardation of tumor growth paired with a marked increase in life-span of the treated animals. Our observations confirm that polyamines absorbed from exogenous sources, mainly food and gastrointestinal tract, play an important role in tumor growth control. Furthermore, the study shows that polyamine deprivation represents an important potential therapeutic tool in improved management of cancer treatment.
Insights
Tumor growth depends on polyamines. Blocking both internal and external polyamine sources significantly reduced tumors and improved cancer treatment outcomes when combined with chemotherapy.
Area of Science:
- Oncology
- Biochemistry
- Cancer Biology
Background:
- Tumors require polyamines for growth, making polyamine biosynthetic enzymes targets for cancer drug development.
- Inhibitors of ornithine decarboxylase (e.g., DFMO) show limited efficacy in vivo due to tumor cells' ability to uptake external polyamines.
Purpose of the Study:
- To investigate the therapeutic potential of polyamine deprivation in cancer treatment.
- To evaluate a strategy combining polyamine-free diets, gastrointestinal decontamination, and chemotherapy.
Main Methods:
- Developed a strategy to block endogenous and exogenous polyamine sources in vivo.
- Administered polyamine-free diets and gastrointestinal decontamination to animals.
- Combined polyamine deprivation with clinically used cytotoxic drugs.
Main Results:
- Significant antitumoral effects observed in Lewis lung carcinoma and Mat Lylu prostatic carcinoma models.
- Restoration of normal biological parameters (blood counts, NK activity) in treated animals.
- Reduced number of metastases and improved survival rates when combined with chemotherapy.
Conclusions:
- Exogenous polyamines from diet and the gut play a crucial role in tumor growth.
- Polyamine deprivation is a promising therapeutic tool for enhancing cancer treatment efficacy.
- Combining polyamine deprivation with chemotherapy improves outcomes by retarding tumor growth and increasing lifespan.